Variant Private Wealth’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Variant Private Wealth’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Buy	+1,093	New	+$209K	0.36%	34

Other funds holding LABU

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Simmons Bank Pine Bluff, Arkansas $1.75B AUM 33.61% 1-Year Est. Return

HHGA

Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Covestor London, United Kingdom $173M AUM 56.91% 1-Year Est. Return

Variant Private Wealth's LABU Position: Q2 2026 in Review

Variant Private Wealth opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 1,093 shares worth $319K. The stake represents 0.36% of the portfolio and ranks #34 among its holdings.

17 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

Variant Private Wealth held 1,093 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $319K as of Q2 2026.
Direxion Daily S&P Biotech Bull 3X ETF was a new Variant Private Wealth position in Q2 2026.
Direxion Daily S&P Biotech Bull 3X ETF made up 0.36% of Variant Private Wealth's portfolio in Q2 2026, its #34 holding.
17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Variant Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.